Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- NeoGenomics Inc: The Wall Street Analyst Forum Presentation Transcript
- Earnings Call Excerpt NeoGenomics Inc. NGNM Wall Street Analyst Forum Presentation November 28, 2007 10:30 am ET Executives Robert Gasparini – President & Chief Science Officer Steven Jones - Chief Financial Officer Presentation Moderator Good morning ladies and gentlemen. I’d like to go ahead and introduce the next company...
- Earnings calls 2007-11-28
Additional Resources
- Humphrey Cancer Center Patients Benefit from Genetics Counseling Effort
- COON RAPIDS, Minn. -- Cancer experts say that many people who could benefit from cancer genetic services never receive them. Health care providers who treat cancer patients say determining which patients should see a genetic counselor can be time-consuming and complicated. "There are many different known inherited conditions that...
- Research articles 2006-06-05
- Aetna to Offer Access to Confidential Telephonic Cancer Genetic Counseling to Health Plan Members
- -- Genetic Counseling Helps Individuals and Their Doctors Assess Their Risk for Cancer, Appropriately Order and Interpret Genetic Tests, and Make Informed Screening and Preventive Decisions --
- Research articles 2007-11-27
- Commonwealth Biotechnologies, Inc. to Participate in NCI Sponsor Clinical Trial; Conduct of Molecular Screening Assays for Early Detection of Bladder Cancer Genetic Markers
- RICHMOND, Va. -- Commonwealth Biotechnologies, Inc. (NASDAQ: CBTE), is pleased to announce that it has been qualified and selected by the National Cancer Institute to perform molecular assays as part of a clinical trial to test the efficacy of the first DNA-based bladder cancer diagnostic. CBI will perform the assay...
- Research articles 2004-09-30
- Increased Risk of Cancer Among Relatives of Patients With Lung Cancer in China
- Genetic factors were considered as one of the risk factors for lung cancer or other cancers. The aim of this paper was to determine whether a genetic predisposition accounts for such familial aggregation of cancer among relatives of lung cancer probands. A case-control study was conducted in 800 case families...
- White papers 2005-11-11
- MDS Provides New Genetic Test for Colon and Uterine Cancer, Canadians with family history of colon cancer now being analyzed with Myriad's COLARIS(TM) genetic test.
- TORONTO, Dec 06, 2000 MDS Inc. (NYSE:MDZ, TSE:MDS) announced today that COLARISTM, Myriad Genetics, Inc.'s new genetic predictive test for colon and uterine cancer is now available across Canada through the MDS national network. The COLARIS test detects disease-causing mutations in two genes,...
- Research articles 2000-12-06
- Ten new genetic clues for prostate cancer
- PARIS AFP — Gene sleuths have identified more than 10 new genetic links to prostate cancer, two of which would be included in a new diagnostic test aimed at spotting men at risk from this disease. Prostate cancer is the commonest cancer afflicting men in developed countries and heredity...
- Research articles 2008-02-10
- New Genetic Test Helps Canadians in the Fight Against Colon Cancer.
- TORONTO, Oct 19, 2000 MDS (NYSE:MDZ/TSE:MDS) announced today that, through the MDS national network, Canadians will have another new test to identify genetic susceptibility to cancer. This new test, COLARISTM, identifies individual susceptibility to colon and uterine cancers based on an analysis of...
- Research articles 2000-10-19
- Local firm's genetic test gets a workout in study.(Vysis Inc. breast cancer gene test)(Brief Article)
- Vysis Inc. of Downers Grove is going under the microscope-quite willingly. The maker of genetic tests was selected last month to provide a critical tool to an international research group that's tracking a telltale gene believed to be linked to breast cancer. ...
- Research articles 2001-01-08
- Jefferson Scientists Devise Way to See Breast Cancer Activity from Outside the Body.
- Byline: Thomas Jefferson University PHILADELPHIA, Dec. 10 AScribe Newswire -- Using precise, radioactively labeled genetic probes, researchers at Jefferson Medical College have seen cancer gene activity from outside the body in laboratory mice. The probes, which work by attaching to genetic codes copied...
- Research articles 2004-12-10
- Genetic breast cancer test helps refine treatment plans
- Spokane-based Rockwood Clinic PS is participating in a clinical study of a technique to identify genetic markers in cancerous breast tumors that can help doctors predict whether a cancer patient is at risk for developing metastatic cancer later. Already, Rockwood specialists have altered two patients' treatment plans because of results...
- Research articles 2009-03-26
- Pro-Pharmaceuticals Featured in 'Genetic Engineering News' Overview of Innovative Cancer Therapy Research
- Business/Technology Editors & Health/Medical Writers NEWTON, Mass.--BUSINESS WIRE--Sept. 25, 2002 Pro-Pharmaceuticals Inc. (OTCBB:PROH), a developer of molecular techniques to enhance the delivery and effectiveness of proven anti-cancer drugs, is showcased in an overview of novel cancer research efforts appearing in the current issue of Genetic Engineering News, the...
- Research articles 2002-09-25
- Blood plasma reveals cancer.(SHORT TAKES)(Quest Diagnostics Inc. )(Brief article)
- Quest Diagnostics Inc. has launched the first of its Leumeta cancer testing assays, designed as an alternative to bone marrow biopsies which everyone would prefer to avoid. The assays identify and analyze genetic components of leukemia and lympho Quest Diagnostics Inc. has launched the...
- Research articles 2006-07-01
- US considers cancer genome project
- WASHINGTON AFP — US scientists are considering creating a complete catalogue of genetic anomalies characteristic of cancer in a new effort to combat the deadly disease, the director of the National Human Genome Institute said. The institute plans to establish the DNA sequence in at least 12,500 samples of...
- Research articles 2005-03-28
- Pill pops breast cancer gene.
- Aug 31, 2005 (Australasian Science - ABIX via COMTEX) -- A Melbourne study has found oral contraceptives reduce the risk of one genetic type of breast cancer. Professor John ...
- Research articles 2005-08-31
- Whatman Provides FTA® Elute to NCRI Prostate Cancer Biomarker Study
- MRC Clinical Trials Unit to Implement Whatman FTA Elute in DNA Collection and Preparation Kits to Study Genetic Markers Affecting Prostate Cancer Treatments FLORHAM PARK, N.J. -- Whatman, a global leader in separations technology, today announced that it will provide DNA collection kits based on its proprietary FTA([R]) Elute...
- Research articles 2007-08-27
- California Pacific Medical Center Research Institute Study Finds Cells from ''Normal-Appearing'' Part of Colon Have Early Genetic Changes
- Business Editors/Health/Medical Writers SAN FRANCISCO--BUSINESS WIRE--May 24, 2004 Finding May Have Implications for Screening, Early Diagnosis, Prevention of Colon Cancer Research published in the May 15th issue of Cancer Research by a collaborative group of researchers, pathologists and physicians at California Pacific Medical Center finds that...
- Research articles 2004-05-24
- Millennium Discovers Markers Associated With Chemotherapy Response in Breast Cancer Patients
- This article elaborates and gives information about breast cancer patients. Millennium Pharmaceuticals discusses the results from a preliminary, prospective study seeking to identify novel genetic predictors of breast cancer patients' response to chemotherapy. Findings from the study demonstrated that a five-gene marker set predicted, with 81% accuracy, a complete response...
- White papers 2002-12-11
- Bush urges ban on 'genetic discrimination'
- WASHINGTON AFP — US President George W. Bush urged the US Congress to ban genetic discrimination, a step some experts say would encourage Americans to test for major health risks such as cancer. "I really want to make it clear to the Congress that I hope they pass legislation that...
- Research articles 2007-01-17
- Illumina Announces Agreement for Sale of Production-Scale Genetic Analysis Laboratory
- SAN DIEGO -- BeadArrayTM Technology to Enable Landmark Genotyping And Gene Expression Studies of Cancer and Other Complex Diseases Illumina, Inc. (Nasdaq:ILMN) today announced an agreement with Mayo Clinic for the purchase and installation of an IlluminaR BeadLab at the clinic's Rochester, Minnesota location. The BeadLab, a production-scale genetic...
- Research articles 2005-01-19
- << Previous
- page 1 of 1
- Next >>
